Advanced Search

Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2009 June;61(3) > Minerva Pediatrica 2009 June;61(3):263-72

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,723

Frequency: Bi-Monthly

ISSN 0026-4946

Online ISSN 1827-1715

Minerva Pediatrica 2009 June;61(3):263-72

INTESTINAL FAILURE AND REHABILITATION 

    REVIEWS

What is the current role for parenteral lipid emulsions containing omega-3 fatty acids
in infants with short bowel syndrome?

Diamond I. R., Pencharz P. B., Wales P. W.

Group for Improvement of Intestinal Function and Treatment (GIFT) Hospital for Sick Children, Toronto, ON, Canada

Parenteral nutrition associated liver disease is the most common complication of pediatric short bowel syndrome (SBS). There is emerging evidence that the disease may be reversed with the use of parenteral lipid emulsions derived from fish-oils, which contain significant concentrations of omega-3 fatty acids (w3FA). This paper will review the rationale for the use of parenteral lipid emulsions containing w3FA in SBS and the evidence for their efficacy. Given the promising results and apparent safety of these emulsions, we shall also consider what the current role for PN lipid emulsions containing w3FA in children with SBS should be.

language: English


FULL TEXT  REPRINTS

top of page